Repository logo
 

Fabrication of free standing collagen membranes by pulsed-electrophoretic deposition.

Published version
Peer-reviewed

Change log

Abstract

This work reports an important new development in the production of collagen membranes, based on pulsed electrophoretic deposition (P-EPD), suitable for a wide range of biomedical applications. Collagen membranes are of great interest as a biomaterial and in a range of other industries, though current production techniques suffer from limitations with scaling up, homogeneity, and complex shapes. P-EPD can be used to rapidly create detachable, large-area, homogeneous products with controlled thickness in a wide variety of shapes. We provide a new understanding of the influence of a range of parameters (pulse width, voltage, duty cycle, solvent additions) and their effects on membrane structure. Characterisation by AFM, SEM, and cryoSEM revealed the ability to produce dense, structurally defect-free membranes, and significantly, we show and discuss the ability to produce thicker membranes by sequential deposition without seeing a corresponding increase in cell electrical resistance. We anticipate this novel, rapid, and controllable method for the production of collagen membranes to be of interest for a wide range of fields.

Description

Journal Title

Biofabrication

Conference Name

Journal ISSN

1758-5082
1758-5090

Volume Title

11

Publisher

IOP Publishing

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
European Research Council (320598)
EPSRC (1365562)
Engineering and Physical Sciences Research Council (EP/K503009/1)
Engineering and Physical Sciences Research Council (EP/L504920/1)
Engineering and Physical Sciences Research Council (EP/M506485/1)
Engineering and Physical Sciences Research Council (EP/M508007/1)
The authors wish to acknowledge the support of theEngineering and Physical Sciences Research Council(EPSRC)grants EP/K503009/1, EP/J500380/1, EP/L504920/1, EP/M506485/1, and EP/M508007/1,Geistlich Pharma AG, and the European ResearchCouncil(ERC)Advanced Grant 320598 3D-E